Delivery Order SPE2DB22D9130-SPE2DB24FE0CU

Award Date 2/26/24
Potential Completion Date 3/18/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,688.80 contract is for the delivery of 100-unit vials of Botox, with a period of performance through August 20, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,768.88 contract is for the delivery of BOTOX 100 unit vials and has a completion date of September 5, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which enables the agency to place orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $13,704 contract is for the delivery of 100-unit BOTOX vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $18,459.20 contract is for the delivery of BOTOX 100 unit vials, with a performance period through March 6, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued up to $4,999,999, to provide a broad range of pharmaceutical items to military health facilities...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,307.40 and has an ultimate completion date of May 23, 2024. It is not associated with a larger indefinite delivery contract vehicle. The contract does not have a set-aside designation. Under this delivery order, DMS Pharmaceutical Group Inc. will provide the...
This is a firm fixed-price delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,768.88 contract is for the delivery of 100-unit vials of Botox to DLA's facility in Park Ridge, Illinois by March 20, 2024. DMS Pharmaceutical Group Inc. holds a separate $4,999,999 indefinite delivery contract with DLA under the SPE2DB program to provide a broad range of pharmaceutical products and medical supplies...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,845.92 and an ultimate completion date of April 17, 2024. DMS Pharmaceutical Group is supplying Botox 100 unit vials to the DLA under this delivery order, which is part of a larger indefinite delivery contract (IDC) between the company and...
This is a firm fixed-price delivery order worth $16,613.28 awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,836.20 award is for the delivery of 200-unit vials of Botox, a specialized pharmaceutical product, with a completion date of March 24, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,836.20 contract is for the delivery of 200-unit vials of Botox by June 4, 2025. DMS Pharmaceutical Group Inc. specializes in providing a comprehensive range of pharmaceutical products to federal agencies, particularly the Department of Defense healthcare system. The company holds a significant single-award...
  • SPE2DB22D9130
    Indefinite Delivery Contract
  • SPE2DB22D9130-SPE2DB24FE0CU
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $1,845.92 contract is for the supply of 100-unit vials of BOTOX, with a completion date of March 18, 2024. The award is not associated with a larger contract vehicle, and there is no set-aside designation. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA valued at up to $4,999,999 through 2025, which enables the agency to place delivery orders for a broad range of pharmaceutical products to support military health facilities worldwide.

Generated 6/2/24, 12:21 AM